Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Diagnostic and Prognostic Value of Epigenetic Markers in Neurological Diseases. A Narrative Review.
Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.
Recent advances in neurodegenerative diseases therapeutics: The inhibition of monoacylglycerol lipase strategy.
Activation of the Reverse Cholesterol Transport Pathway: A Strategy to Ameliorate Lipid Metabolic Dyshomeostasis in the Microenvironment Following Spinal Cord Injury.
Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis.
How can social cognition be improved in neurological patients? a systematic review.
Formyl peptide and its receptor system as a novel target for the prevention and treatment of neuroinflammation-related diseases.
Single cell transcriptome profiling of peripheral blood mononuclear cells in Guillain-Barré syndrome patients.
Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria.
A network meta-analysis of the performance of acupoint stimulation therapy in improving fatigue, neurological function, and activities of daily living in patients with multiple sclerosis.
Biodistribution and toxicity of inhaled nickel oxide nanoparticles: Potential application to realistic exposure.
Chronic exposure to LED lighting impairs prefrontal cortex-dependent cognitive functions in adolescent rats.
Fer-1 improves cognitive dysfunction in chronic kidney disease through the Sirt2/PGC-1α signaling pathway based on RNA sequencing.
Differential Roles of IL-18 and IL-8 Gene Variations in Multiple Sclerosis: Associations with Susceptibility and MRI Disease Activity.
Burden of 292 causes of death and life expectancy decomposition in Iran, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammation.
T cell-microglial interactions that impair myelin maintenance and regeneration: cellular mechanisms on white-matter associated changes.
Pilot Ultrastructural Observations of Trauma-Associated Myelin Alterations in Human Autopsy Brain Tissue Following Fatal Road Traffic Injury.
Black phosphorus nanosheet-enabled ROS-adaptive core-shell microneedles orchestrate immunoredox remodeling and neurotrophic regeneration for facial nerve repair.
Clinical feature of anti-myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with cerebrospinal fluid anti-N-methyl-D-aspartate receptor antibody co-positivity: a single center case series.
Charting the transition from in vitro gliogenesis to the in vivo maturation of human glial progenitor cells transplanted into the hypomyelinated mouse brain.
Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review.
Should autologous HSCT be a first-line option in highly active MS: YES.
Updated systematic literature review and network meta-analysis of cladribine tablets versus currently approved disease-modifying treatments for active relapsing-remitting multiple sclerosis.
Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventions.
Pages
« first
‹ previous
…
970
971
972
973
974
975
976
977
978
…
next ›
last »